Sign Up Today and Learn More About MBrace Therapeutics Stock
Invest in or calculate the value of your shares in MBrace Therapeutics or other pre-IPO companies through EquityZen's platform.
MBrace Therapeutics Stock (MBTH)
MBrace MBrace Therapeutics is a privately held biopharmaceutical business.
About MBrace Therapeutics Stock
Founded
2019
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
MBrace Therapeutics Press Mentions
Stay in the know about the latest news on MBrace Therapeutics
MBrace Therapeutics Presents Trial in Progress Poster for Lead Antibody-Drug Conjugate Program at 2024 ASCO Annual Meeting
finance • Aug 03, 2024
MBrace Therapeutics on LinkedIn: #chieflegalofficer #biotech #pharmaceutical #legal | 24 comments
linkedin • Aug 03, 2024
MBrace Therapeutics Presents Trial in Progress Poster for Lead Antibody-Drug Conjugate Program at 2024 ASCO ...
businesswire • Jun 04, 2024
MBrace Therapeutics on LinkedIn: MBrace Therapeutics Appoints Steve Alley as Chief Scientific Officer | 21 comments
linkedin • Apr 06, 2024
MBrace Therapeutics Appoints Steve Alley as Chief Scientific Officer
businesswire • Mar 05, 2024
Join now and verify your accreditation status to gain access to:
- MBrace Therapeutics current valuation
- MBrace Therapeutics stock price
- Available deals in MBrace Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in MBrace Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like MBrace Therapeutics through EquityZen funds. These investments are made available by existing MBrace Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell MBrace Therapeutics stock?
Shareholders can sell their MBrace Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
